Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-pr003
Silvana C.E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane
The incidence of early-onset colorectal cancer (eoCRC) has risen worldwide, yet the drivers of this trend remain poorly understood. Directly investigating the exposome as a possible risk factor has been hindered by limited data availability, particularly beyond standard lifestyle factors, such as an unhealthy diet and smoking. To enable the study of a greater variety of exposome factors, we investigated the possibility of using DNA methylation as an indirect biomarker for the exposome. We derived methylation scores (MSs) for 29 exposures, including lifestyle, air pollution, and pesticides, based on published epigenome-wide association studies. These MSs were used to compare eoCRC and later-onset CRC (loCRC) tumors in The Cancer Genome Atlas (TCGA) Colon Adenocarcinoma cohort (31 eoCRC vs. 100 loCRC), followed by replication through meta-analysis across nine independent studies (83 eoCRC vs. 272 loCRC). For exposures within the selected 29 factors where direct measurements were available, MSs consistently reflected associations with measured exposures in tumor or blood profiles. Moreover, our approach successfully identified established risk factors for eoCRC, such as lower educational attainment, smoking, and non-Mediterranean dietary patterns, further validating the proposed methodology. Besides validating our proposed methodology, we identified picloram, an herbicide classified as IARC Group 3, as a potential novel risk factor. To address the limited methylation data on picloram, we integrated transcriptomic profiles from pluripotent stem cell–derived cardiomyocytes exposed to picloram. Differentially expressed genes under exposure were used to construct a picloram-specific single-sample GSEA (ssGSEA) score in TCGA-COAD, which showed significant correlation with the picloram-MS. At the population level, we further linked U.S. county-level eoCRC incidence from the SEER program to picloram application estimates (NAWQA Project, 1992–2012). This relationship remained significant after adjusting for socioeconomic indicators and other pesticide use. Together, these findings demonstrate the utility of MSs as effective proxies in exposome research and demonstrate their ability to uncover novel environmental risk factors. Beyond confirming known contributors, our study highlights picloram as a candidate exposure associated with eoCRC, supported by evidence across methylation, transcriptomic, and population data. These results underscore exposome differences between eoCRC and loCRC and suggest opportunities for prevention through exposome modification and regulatory policy. Citation Format: Silvana C.E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane. Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research
早发性结直肠癌(eoCRC)的发病率在全球范围内上升,但这一趋势的驱动因素仍然知之甚少。由于可获得的数据有限,特别是除了不健康的饮食和吸烟等标准生活方式因素之外,直接将接触物作为可能的风险因素进行调查一直受到阻碍。为了能够研究更多种类的暴露体因素,我们研究了使用DNA甲基化作为暴露体的间接生物标志物的可能性。基于已发表的全表观基因组关联研究,我们得出了29种暴露的甲基化评分(MSs),包括生活方式、空气污染和农药。这些MSs用于比较癌症基因组图谱(TCGA)结肠腺癌队列中的eoCRC和晚发性CRC (loCRC)肿瘤(31个eoCRC vs 100个loCRC),随后通过9个独立研究(83个eoCRC vs 272个loCRC)的荟萃分析进行复制。对于可直接测量的选定的29个因素中的暴露,MSs一致地反映了与肿瘤或血液谱中测量的暴露的关联。此外,我们的方法成功地确定了eoCRC的既定风险因素,如教育程度低、吸烟和非地中海饮食模式,进一步验证了所提出的方法。除了验证我们提出的方法外,我们还将picloram(一种被IARC分类为第3类的除草剂)确定为潜在的新风险因素。为了解决picloram有限的甲基化数据,我们整合了暴露于picloram的多能干细胞来源的心肌细胞的转录组谱。使用暴露下的差异表达基因构建TCGA-COAD中picloram特异性单样本GSEA (ssGSEA)评分,该评分与picloram-MS有显著相关性。在人口水平上,我们进一步将美国县级eoCRC发病率从SEER项目与picloram应用估计联系起来(NAWQA项目,1992-2012)。在调整了社会经济指标和其他农药使用后,这种关系仍然显著。总之,这些发现证明了MSs在暴露研究中作为有效代理的效用,并证明了它们发现新的环境风险因素的能力。除了确认已知的致病因素外,我们的研究还强调了picloram作为与eoCRC相关的候选暴露,并得到了甲基化、转录组学和人群数据的证据支持。这些结果强调了eoCRC和loCRC之间的暴露差异,并提出了通过暴露体修改和监管政策进行预防的机会。引文格式:Silvana C.E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane。利用甲基化评分探讨暴露对早发性结肠癌和直肠癌的影响[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): nr PR003。
{"title":"Abstract PR003: Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores","authors":"Silvana C.E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane","doi":"10.1158/1557-3265.earlyonsetca25-pr003","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-pr003","url":null,"abstract":"The incidence of early-onset colorectal cancer (eoCRC) has risen worldwide, yet the drivers of this trend remain poorly understood. Directly investigating the exposome as a possible risk factor has been hindered by limited data availability, particularly beyond standard lifestyle factors, such as an unhealthy diet and smoking. To enable the study of a greater variety of exposome factors, we investigated the possibility of using DNA methylation as an indirect biomarker for the exposome. We derived methylation scores (MSs) for 29 exposures, including lifestyle, air pollution, and pesticides, based on published epigenome-wide association studies. These MSs were used to compare eoCRC and later-onset CRC (loCRC) tumors in The Cancer Genome Atlas (TCGA) Colon Adenocarcinoma cohort (31 eoCRC vs. 100 loCRC), followed by replication through meta-analysis across nine independent studies (83 eoCRC vs. 272 loCRC). For exposures within the selected 29 factors where direct measurements were available, MSs consistently reflected associations with measured exposures in tumor or blood profiles. Moreover, our approach successfully identified established risk factors for eoCRC, such as lower educational attainment, smoking, and non-Mediterranean dietary patterns, further validating the proposed methodology. Besides validating our proposed methodology, we identified picloram, an herbicide classified as IARC Group 3, as a potential novel risk factor. To address the limited methylation data on picloram, we integrated transcriptomic profiles from pluripotent stem cell–derived cardiomyocytes exposed to picloram. Differentially expressed genes under exposure were used to construct a picloram-specific single-sample GSEA (ssGSEA) score in TCGA-COAD, which showed significant correlation with the picloram-MS. At the population level, we further linked U.S. county-level eoCRC incidence from the SEER program to picloram application estimates (NAWQA Project, 1992–2012). This relationship remained significant after adjusting for socioeconomic indicators and other pesticide use. Together, these findings demonstrate the utility of MSs as effective proxies in exposome research and demonstrate their ability to uncover novel environmental risk factors. Beyond confirming known contributors, our study highlights picloram as a candidate exposure associated with eoCRC, supported by evidence across methylation, transcriptomic, and population data. These results underscore exposome differences between eoCRC and loCRC and suggest opportunities for prevention through exposome modification and regulatory policy. Citation Format: Silvana C.E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane. Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research ","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"4 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Early-onset colorectal cancer (EOCRC) is rising among adults aged 18–49, with Georgia showing particularly high mortality rates. Racial minorities (e.g., Black or Hispanic adults) in the state are more likely to face higher obesity rates and live in areas with limited access to healthy food and safe spaces for physical activity- factors that may hinder healthy lifestyle adoption and worsen cancer outcomes. However, most research on obesity and EOCRC mortality relies on either ecological or individual-level data and rarely examines changes in survival over time. By integrating county-level obesity rates into individual-level data, we evaluated how structural barriers affect cause-specific EOCRC survival across racial groups and time intervals in Georgia. Methods: We conducted a retrospective cohort study using data from the 2010-2020 Georgia Cancer Registry, linked with County Health Rankings. The primary exposures were race/ethnicity (White, Black, Hispanic/Other) and log-transformed county-level obesity rates (body mass index, [BMI] ≥ 30), categorized as low vs. high based on the median value. Outcome was survival time from diagnosis to 12, 36, and 60 months, censored at death from other causes or at the date of last contact. Traditional and piecewise Cox regression models were used, adjusting for sociodemographic characteristics (sex, age at diagnosis, marital status, insurance status, county-level rurality, and poverty), stage at diagnosis, and diagnosis year. Results: Among 6,291 EOCRC patients, 63.4% lived in high-obesity areas, and 53.3% were White patients. White patients living in high-obesity areas had significantly lower 3-year (76.6% vs. 81.1%; p=0.002) and 5-year (71.3% vs. 75.7%; p =0.001) survival rates compared to those in low-obesity areas. Survival differences were not observed for Black and Hispanic/Other patients. Adjusted analysis showed that patients living in high-obesity areas were 14% more likely to die from CRC than those living in low-obesity areas at both 3- (HR,1.14; 95% CI, 1.02-1.28) and 5-year (HR,1.14; 95% CI, 1.03-1.27) intervals, whereas White patients specifically were 32% (HR,1.32; 95% CI, 1.11-1.54) and 33% (HR,1.33; 95% CI, 1.13-1.50) more likely to die from CRC, respectively. Piecewise models revealed a 29% increased risk of CRC mortality within 1–3 years (HR,1.29; 95% CI, 1.11–1.50), with subgroup analysis showing an even higher 51% risk for White patients during the same interval (HR,1.51; 95% CI, 1.21–1.89). Conclusions: Distinct results between traditional and piecewise models suggest that mortality risk varies over time, with elevated risk in the first 1–3 years for White patients in high-obesity areas. These findings support targeted efforts to promote healthy lifestyles and invest in infrastructure that fosters healthier living to reduce early mortality. Finally, our study did not observe similar disparities among racial minorities due to limited sample size that could reduce the power to
{"title":"Abstract B035: Multilevel Insights into Obesity, Race/Ethnicity, and Survival in Early-Onset Colorectal Cancer in Georgia","authors":"Meng-Han Tsai, Marlo Vernon, Malcolm Bevel, Humberto Sifuentes, Jorge Cortes, Rebecca L. Siegel","doi":"10.1158/1557-3265.earlyonsetca25-b035","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b035","url":null,"abstract":"Background: Early-onset colorectal cancer (EOCRC) is rising among adults aged 18–49, with Georgia showing particularly high mortality rates. Racial minorities (e.g., Black or Hispanic adults) in the state are more likely to face higher obesity rates and live in areas with limited access to healthy food and safe spaces for physical activity- factors that may hinder healthy lifestyle adoption and worsen cancer outcomes. However, most research on obesity and EOCRC mortality relies on either ecological or individual-level data and rarely examines changes in survival over time. By integrating county-level obesity rates into individual-level data, we evaluated how structural barriers affect cause-specific EOCRC survival across racial groups and time intervals in Georgia. Methods: We conducted a retrospective cohort study using data from the 2010-2020 Georgia Cancer Registry, linked with County Health Rankings. The primary exposures were race/ethnicity (White, Black, Hispanic/Other) and log-transformed county-level obesity rates (body mass index, [BMI] ≥ 30), categorized as low vs. high based on the median value. Outcome was survival time from diagnosis to 12, 36, and 60 months, censored at death from other causes or at the date of last contact. Traditional and piecewise Cox regression models were used, adjusting for sociodemographic characteristics (sex, age at diagnosis, marital status, insurance status, county-level rurality, and poverty), stage at diagnosis, and diagnosis year. Results: Among 6,291 EOCRC patients, 63.4% lived in high-obesity areas, and 53.3% were White patients. White patients living in high-obesity areas had significantly lower 3-year (76.6% vs. 81.1%; p=0.002) and 5-year (71.3% vs. 75.7%; p =0.001) survival rates compared to those in low-obesity areas. Survival differences were not observed for Black and Hispanic/Other patients. Adjusted analysis showed that patients living in high-obesity areas were 14% more likely to die from CRC than those living in low-obesity areas at both 3- (HR,1.14; 95% CI, 1.02-1.28) and 5-year (HR,1.14; 95% CI, 1.03-1.27) intervals, whereas White patients specifically were 32% (HR,1.32; 95% CI, 1.11-1.54) and 33% (HR,1.33; 95% CI, 1.13-1.50) more likely to die from CRC, respectively. Piecewise models revealed a 29% increased risk of CRC mortality within 1–3 years (HR,1.29; 95% CI, 1.11–1.50), with subgroup analysis showing an even higher 51% risk for White patients during the same interval (HR,1.51; 95% CI, 1.21–1.89). Conclusions: Distinct results between traditional and piecewise models suggest that mortality risk varies over time, with elevated risk in the first 1–3 years for White patients in high-obesity areas. These findings support targeted efforts to promote healthy lifestyles and invest in infrastructure that fosters healthier living to reduce early mortality. Finally, our study did not observe similar disparities among racial minorities due to limited sample size that could reduce the power to ","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"30 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-pr012
Sheetal Hardikar, Griffin Caryotakis, David A. Nix, Aaron Atkinson, Jamie Teer, Vaia Florou, Andreana Holowatyj, Michelle L. Churchman, David M. McKean, Phaedra Agius, Bodour Salhia, Ning Jin, Daniel Spakowicz, Micha Cavnar, Emily Baiyee. Toegel, Tiago Biachi de Castria, Patrick M. Boland, Ahmad Tarhini, Bryan P. Schneider, Matthew Reilley, Deepak Vadehra, Michele M. Gage, Howard Colman, Courtney Scaife, Jessica N. Cohan, Biljana Gigic, Adetunji Toriola, Christopher I. Li, Jane Figueiredo, Dorotha Byrd, David Shibata, Cornelia M. Ulrich, Aik Choo Tan, Erin M. Siegel
Introduction: Although ∼20% of early-onset colorectal cancer (EOCRC, age at diagnosis <50y) cases are due to germline mutations, the etiology of the majority of EOCRC cases remains poorly understood. EOCRC differs molecularly from late-onset colorectal cancer (LOCRC, age at diagnosis > 70y), with EOCRC tumors more frequently exhibiting high-grade histology, immune-related signatures, and microsatellite instability, while LOCRC is marked by DNA damage and oxidative stress pathways. Although consensus molecular subtypes (CMS) offer a framework for classification, they do not fully explain the rising EOCRC incidence, highlighting the need for integrative multiomic approaches to uncover underlying genetic, epigenetic, and environmental drivers for EOCRC. Methods: We leveraged genomic, transcriptomic, and clinical data from 1,135 sporadic microsatellite stable colorectal cancer (CRC) patients enrolled in the Total Cancer Care protocol and included in the Oncology Research Information Exchange Network (ORIEN) Avatar program across seven U.S. cancer centers, using standardized protocols for biospecimen collection, sequencing, and data harmonization. Whole exome sequencing (WES) and transcriptomic profiling (RNA-Seq) was conducted using standardized pipelines, followed by normalization and filtering. We characterized biological differences across EOCRC and LOCRC using differential expression, molecular subtyping, immune deconvolution, survival analysis, and integrated pathway analyses combining RNA-seq and WES data. Results: Our cohort included 27.8% EOCRC, 53.5% average-onset (50-69y) and 18.9% LOCRC cases. EOCRC patients were more likely to present with rectal tumors (24% vs. 14%), advanced stage (75% vs. 57%), and receive treatments at a higher proportion (radiotherapy: 35% vs. 23%; adjuvant therapy: 51% vs. 37%) compared to LOCRC. No significant differences were observed in common CRC mutations or tumor mutational burden. EOCRC cases were significantly enriched for the mesenchymal CMS4 subtype and depleted in CMS2 and CMS3 (p < 9.46 × 10-6), though 5-year survival did not differ by CMS (p-value=0.23). Notably, we observed that EOCRC cases with CMS2 or CMS4 were more likely to be overweight (BMI >= 25kg/m2) as compared to LOCRC (OR > 2). Transcriptomic analysis identified 328 differentially expressed genes (306 up-regulated and 22 down-regulated in EOCRC); GSEA analysis showed enrichment of Hedgehog and calcium signaling pathways (FDR < 0.1) in EOCRC. Conclusions: This comparison of EOCRC and LOCRC cases demonstrates clear differences in CMS subtypes, reveals specific associations with environmental factors, and suggests that calcium channel signaling and hedgehog signaling may play a crucial role in the development and progression of EOCRC compared to LOCRC. Citation Format: Sheetal Hardikar, Griffin Caryotakis, David A. Nix, Aaron Atkinson, Jamie Teer, Vaia Florou, Andreana Holowatyj, Michelle L. Churchman,
导读:虽然约20%的早发性结直肠癌(EOCRC,诊断年龄为50岁)病例是由种系突变引起的,但大多数EOCRC病例的病因学仍然知之甚少。EOCRC在分子上不同于晚发性结直肠癌(LOCRC,诊断年龄70岁),EOCRC肿瘤更频繁地表现出高级别组织学、免疫相关特征和微卫星不稳定性,而LOCRC则以DNA损伤和氧化应激途径为特征。尽管共识分子亚型(CMS)提供了一个分类框架,但它们并不能完全解释EOCRC发病率上升的原因,因此需要综合多组学方法来揭示EOCRC潜在的遗传、表观遗传和环境驱动因素。方法:我们利用基因组学、转录组学和临床数据,这些数据来自美国7个癌症中心的1135名散在微卫星稳定型结直肠癌(CRC)患者,这些患者加入了癌症总护理方案,并纳入了肿瘤研究信息交换网络(ORIEN) Avatar项目,使用标准化的生物标本收集、测序和数据协调协议。采用标准化管道进行全外显子组测序(WES)和转录组分析(RNA-Seq),然后进行归一化和过滤。我们通过差异表达、分子分型、免疫反褶积、生存分析以及结合RNA-seq和WES数据的综合通路分析来表征EOCRC和LOCRC之间的生物学差异。结果:我们的队列包括27.8%的EOCRC, 53.5%的平均发病(50-69岁)和18.9%的LOCRC病例。与LOCRC相比,EOCRC患者更有可能出现直肠肿瘤(24%对14%),晚期(75%对57%),并且接受治疗的比例更高(放疗:35%对23%;辅助治疗:51%对37%)。在常见CRC突变或肿瘤突变负荷方面未观察到显著差异。间质CMS4亚型的EOCRC病例显著增多,而CMS2和CMS3亚型的EOCRC病例明显减少(p < 9.46 × 10-6),尽管5年生存率与CMS没有差异(p值=0.23)。值得注意的是,我们观察到与LOCRC (or > 2)相比,伴有CMS2或CMS4的EOCRC病例更有可能超重(BMI >= 25kg/m2)。转录组学分析发现328个差异表达基因(306个在EOCRC中上调,22个下调);GSEA分析显示,在EOCRC中,Hedgehog和钙信号通路(FDR < 0.1)富集。结论:EOCRC与LOCRC病例的比较显示了CMS亚型的明显差异,揭示了与环境因素的特定关联,提示钙通道信号和刺猬信号可能在EOCRC与LOCRC的发生进展中起关键作用。引文格式:Sheetal Hardikar, Griffin Caryotakis, David A. Nix, Aaron Atkinson, Jamie Teer, Vaia Florou, Andreana Holowatyj, Michelle L. Churchman, David M. McKean, Phaedra Agius, Bodour Salhia, Ning Jin, Daniel Spakowicz, Micha Cavnar, Emily Baiyee。Toegel、Tiago Biachi de Castria、Patrick M. Boland、Ahmad Tarhini、Bryan P. Schneider、Matthew Reilley、Deepak Vadehra、Michele M. Gage、Howard coleman、Courtney Scaife、Jessica N. Cohan、Biljana Gigic、addetunji Toriola、Christopher I. Li、Jane Figueiredo、Dorotha Byrd、David Shibata、Cornelia M. Ulrich、Aik Choo Tan、Erin M. Siegel。早发性和晚发性微卫星稳定性结直肠癌的转录组学和通路分析模式:来自ORIEN网络的结果[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): nr PR012。
{"title":"Abstract PR012: Transcriptomic and pathway analyses patterns in early-onset and late-onset microsatellite stable colorectal cancer: Results from the ORIEN Network","authors":"Sheetal Hardikar, Griffin Caryotakis, David A. Nix, Aaron Atkinson, Jamie Teer, Vaia Florou, Andreana Holowatyj, Michelle L. Churchman, David M. McKean, Phaedra Agius, Bodour Salhia, Ning Jin, Daniel Spakowicz, Micha Cavnar, Emily Baiyee. Toegel, Tiago Biachi de Castria, Patrick M. Boland, Ahmad Tarhini, Bryan P. Schneider, Matthew Reilley, Deepak Vadehra, Michele M. Gage, Howard Colman, Courtney Scaife, Jessica N. Cohan, Biljana Gigic, Adetunji Toriola, Christopher I. Li, Jane Figueiredo, Dorotha Byrd, David Shibata, Cornelia M. Ulrich, Aik Choo Tan, Erin M. Siegel","doi":"10.1158/1557-3265.earlyonsetca25-pr012","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-pr012","url":null,"abstract":"Introduction: Although ∼20% of early-onset colorectal cancer (EOCRC, age at diagnosis &lt;50y) cases are due to germline mutations, the etiology of the majority of EOCRC cases remains poorly understood. EOCRC differs molecularly from late-onset colorectal cancer (LOCRC, age at diagnosis &gt; 70y), with EOCRC tumors more frequently exhibiting high-grade histology, immune-related signatures, and microsatellite instability, while LOCRC is marked by DNA damage and oxidative stress pathways. Although consensus molecular subtypes (CMS) offer a framework for classification, they do not fully explain the rising EOCRC incidence, highlighting the need for integrative multiomic approaches to uncover underlying genetic, epigenetic, and environmental drivers for EOCRC. Methods: We leveraged genomic, transcriptomic, and clinical data from 1,135 sporadic microsatellite stable colorectal cancer (CRC) patients enrolled in the Total Cancer Care protocol and included in the Oncology Research Information Exchange Network (ORIEN) Avatar program across seven U.S. cancer centers, using standardized protocols for biospecimen collection, sequencing, and data harmonization. Whole exome sequencing (WES) and transcriptomic profiling (RNA-Seq) was conducted using standardized pipelines, followed by normalization and filtering. We characterized biological differences across EOCRC and LOCRC using differential expression, molecular subtyping, immune deconvolution, survival analysis, and integrated pathway analyses combining RNA-seq and WES data. Results: Our cohort included 27.8% EOCRC, 53.5% average-onset (50-69y) and 18.9% LOCRC cases. EOCRC patients were more likely to present with rectal tumors (24% vs. 14%), advanced stage (75% vs. 57%), and receive treatments at a higher proportion (radiotherapy: 35% vs. 23%; adjuvant therapy: 51% vs. 37%) compared to LOCRC. No significant differences were observed in common CRC mutations or tumor mutational burden. EOCRC cases were significantly enriched for the mesenchymal CMS4 subtype and depleted in CMS2 and CMS3 (p &lt; 9.46 × 10-6), though 5-year survival did not differ by CMS (p-value=0.23). Notably, we observed that EOCRC cases with CMS2 or CMS4 were more likely to be overweight (BMI &gt;= 25kg/m2) as compared to LOCRC (OR &gt; 2). Transcriptomic analysis identified 328 differentially expressed genes (306 up-regulated and 22 down-regulated in EOCRC); GSEA analysis showed enrichment of Hedgehog and calcium signaling pathways (FDR &lt; 0.1) in EOCRC. Conclusions: This comparison of EOCRC and LOCRC cases demonstrates clear differences in CMS subtypes, reveals specific associations with environmental factors, and suggests that calcium channel signaling and hedgehog signaling may play a crucial role in the development and progression of EOCRC compared to LOCRC. Citation Format: Sheetal Hardikar, Griffin Caryotakis, David A. Nix, Aaron Atkinson, Jamie Teer, Vaia Florou, Andreana Holowatyj, Michelle L. Churchman, ","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"8 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-b011
Anna L. Fischer, Guoli Zhou, Kelly A. Hirko
Purpose: The incidence of early-onset breast cancer, diagnosed before age 50 years, has increased significantly in the U.S. and globally in recent decades. While various genetic factors have been implicated in the development of early-onset breast cancer, the role of environmental exposures remains unclear. This study examined associations between ambient air pollution measures and early-onset breast cancer incidence rates in the U.S. Methods: We conducted an ecological analysis of county-level associations between particulate matter <2.5 micrometers (PM2.5) and Nitrogen Dioxide (NO2) exposures (averaged from 2002-2006) and age-adjusted early-onset breast cancer rates (averaged from 2017-2021), accounting for a potential latency period between exposure and diagnosis. The study included 1,422 U.S. counties with available data on pollutants and age-adjusted early-onset breast cancer incidence rates. Generalized additive models were used to estimate associations between pollutants (PM2.5 and NO2 ) and early-onset breast cancer incidence rates, adjusting for county-level prevalence of physical inactivity, college education attainment, poverty, and proportions of Hispanic and non-Hispanic Black populations. Results: After adjusting for confounders, PM2.5 was significantly inversely associated with early-onset breast cancer rates (Tertile 2 vs. Tertile 1: b = -1.66, p=0.01; Tertile 3 vs. Tertile 1: b = -1.85, p=0.01). Similar inverse associations were observed for NO2 (Tertile 2 vs. Tertile 1: b = -1.97, p<0.01); Tertile 3 vs. Tertile 1: b=-2.59, p<0.01). A significant non-linear association between PM2.5 (per 10-unit increase) and early-onset breast cancer rates was detected (estimated degrees of freedom (EDF) = 3.2, p=0.014), with rates increasing up to approximately 10 mcg/m3, then declining at higher concentrations. Conclusion: These findings suggest inverse associations between higher tertiles of PM2.5 and NO2 exposure and early-onset breast cancer rates. However, the observed non-linear relationship between PM2.5 and early-onset breast cancer indicates a possible threshold effect or residual confounding at higher PM2.5 exposure levels. These results underscore the complexity of modeling environmental risk and highlight the need for further research to confirm these findings and investigate underlying biological mechanisms for potential threshold effects. If confirmed, the findings suggest that public health interventions to mitigate air pollution should also target areas with intermediate levels of pollution. Citation Format: Anna L. Fischer, Guoli Zhou, Kelly A. Hirko. Associations between county-level air pollutants and early-onset breast cancer incidence rates in the U.S [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B
目的:近几十年来,在美国和全球范围内,50岁前诊断的早发性乳腺癌的发病率显著增加。虽然各种遗传因素与早发性乳腺癌的发展有关,但环境暴露的作用仍不清楚。本研究考察了美国环境空气污染措施与早发性乳腺癌发病率之间的关系。方法:我们对县级颗粒物(PM2.5)和二氧化氮(NO2)暴露(2002-2006年平均值)与年龄调整的早发性乳腺癌发病率(2017-2021年平均值)之间的关系进行了生态分析,考虑了暴露和诊断之间的潜在潜伏期。这项研究包括了1422个美国县,这些县有污染物和年龄调整后的早发乳腺癌发病率的可用数据。使用广义加性模型来估计污染物(PM2.5和NO2)与早发性乳腺癌发病率之间的关系,调整了县级缺乏体育活动的流行程度、大学教育程度、贫困以及西班牙裔和非西班牙裔黑人人口的比例。结果:调整混杂因素后,PM2.5与早发性乳腺癌发病率呈显著负相关(Tertile 2 vs. Tertile 1: b = -1.66, p=0.01; Tertile 3 vs. Tertile 1: b = -1.85, p=0.01)。NO2也有类似的负相关(Tertile 2 vs. Tertile 1: b = -1.97, p<0.01);Tertile 3 vs. Tertile 1: b=-2.59, p<0.01)。PM2.5(每增加10个单位)与早发性乳腺癌发病率之间存在显著的非线性关联(估计自由度(EDF) = 3.2, p=0.014),发病率增加到约10微克/立方米,然后在浓度较高时下降。结论:这些发现表明,PM2.5和二氧化氮暴露的高浓度与早发性乳腺癌发病率呈负相关。然而,观察到的PM2.5与早发性乳腺癌之间的非线性关系表明,在较高的PM2.5暴露水平下,可能存在阈值效应或残留混淆。这些结果强调了环境风险建模的复杂性,并强调了进一步研究的必要性,以证实这些发现并调查潜在阈值效应的潜在生物学机制。如果得到证实,研究结果表明,减轻空气污染的公共卫生干预措施也应该针对污染程度中等的地区。引用格式:Anna L. Fischer,郭黎,Kelly A. Hirko。美国县级空气污染物与早发性乳腺癌发病率之间的关系[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): B011。
{"title":"Abstract B011: Associations between county-level air pollutants and early-onset breast cancer incidence rates in the U.S","authors":"Anna L. Fischer, Guoli Zhou, Kelly A. Hirko","doi":"10.1158/1557-3265.earlyonsetca25-b011","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b011","url":null,"abstract":"Purpose: The incidence of early-onset breast cancer, diagnosed before age 50 years, has increased significantly in the U.S. and globally in recent decades. While various genetic factors have been implicated in the development of early-onset breast cancer, the role of environmental exposures remains unclear. This study examined associations between ambient air pollution measures and early-onset breast cancer incidence rates in the U.S. Methods: We conducted an ecological analysis of county-level associations between particulate matter &lt;2.5 micrometers (PM2.5) and Nitrogen Dioxide (NO2) exposures (averaged from 2002-2006) and age-adjusted early-onset breast cancer rates (averaged from 2017-2021), accounting for a potential latency period between exposure and diagnosis. The study included 1,422 U.S. counties with available data on pollutants and age-adjusted early-onset breast cancer incidence rates. Generalized additive models were used to estimate associations between pollutants (PM2.5 and NO2 ) and early-onset breast cancer incidence rates, adjusting for county-level prevalence of physical inactivity, college education attainment, poverty, and proportions of Hispanic and non-Hispanic Black populations. Results: After adjusting for confounders, PM2.5 was significantly inversely associated with early-onset breast cancer rates (Tertile 2 vs. Tertile 1: b = -1.66, p=0.01; Tertile 3 vs. Tertile 1: b = -1.85, p=0.01). Similar inverse associations were observed for NO2 (Tertile 2 vs. Tertile 1: b = -1.97, p&lt;0.01); Tertile 3 vs. Tertile 1: b=-2.59, p&lt;0.01). A significant non-linear association between PM2.5 (per 10-unit increase) and early-onset breast cancer rates was detected (estimated degrees of freedom (EDF) = 3.2, p=0.014), with rates increasing up to approximately 10 mcg/m3, then declining at higher concentrations. Conclusion: These findings suggest inverse associations between higher tertiles of PM2.5 and NO2 exposure and early-onset breast cancer rates. However, the observed non-linear relationship between PM2.5 and early-onset breast cancer indicates a possible threshold effect or residual confounding at higher PM2.5 exposure levels. These results underscore the complexity of modeling environmental risk and highlight the need for further research to confirm these findings and investigate underlying biological mechanisms for potential threshold effects. If confirmed, the findings suggest that public health interventions to mitigate air pollution should also target areas with intermediate levels of pollution. Citation Format: Anna L. Fischer, Guoli Zhou, Kelly A. Hirko. Associations between county-level air pollutants and early-onset breast cancer incidence rates in the U.S [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"1 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-b037
Nicole C. Loroña, Jenny Harris, Jane C. Figueiredo
Background: Recent data in the U.S. show a rising rate of early-onset cancers (diagnosed before age 50) over the past decade, with the largest increase in rates seen in the 30-39 age group and the highest number of cases in the 40-49 age group. Simultaneously, the maternal age at the time of pregnancy has increased, with 38% of first births now occurring in women aged 30 and older. The increasing incidence of early-onset cancer, coupled with increasing maternal age, could result in more cancers diagnosed during pregnancy or postpartum. The present study describes trends in the incidence of cancer during pregnancy and postpartum and identifies predictors of pregnancy-associated cancers. Methods: We identified cancer cases diagnosed in adults from 2015 to 2023 with at least one health encounter in the time frame in a large health system in the greater Los Angeles area. We identified patients with obstetric International Classification of Diseases (ICD-10) codes and/or oncology notes mentioning pregnancy in the two years before and six months following the patient’s date of cancer diagnosis. Pregnancy-associated cancer was defined as a diagnosis during pregnancy or within two years postpartum (following any birth, miscarriage, or ectopic pregnancy). Descriptive statistics characterized demographic and cancer-related factors. Results: Among 40,432 patients with cancer during the study period, we identified 217 pregnancy-associated cancers in 216 patients [one individual had thyroid cancer diagnosed following a pregnancy, and breast cancer in a subsequent pregnancy]. Median age at cancer diagnosis was 37 (range: 24-50). 13% of patients were Asian, 6% were Black or African American,15% were Hispanic, and 56% were non-Hispanic White. The majority (n=193, 92%) of pregnancy-associated cancers were solid tumors (vs. 8% hematological), of which the most common sites were breast (N=85, 44%), thyroid (N=35, 18%), cervix (N=13, 7%), central nervous system (N=11, 6%), ovarian (N=8, 4%) and colon (N=6, 3%). Most solid tumors were diagnosed at early stages (50% stage I, 21% stage II vs. 11% stage III, 9% stage IV), with 15 in situ cancers diagnosed (6 breast cancer, 6 gynecologic malignancies, and 3 melanoma). 60 cancers were diagnosed during pregnancy (33% breast and 13% thyroid cancer), 91 during one year postpartum (32% breast and 20% thyroid cancer), and 66 between one and two years postpartum (55% breast and 14% thyroid cancer). Analyses of the total incidence of and predictors of pregnancy-associated cancer are ongoing. Conclusions: Pregnancy-related cancers present challenges for maternal-fetal care and oncology. The two-year interval postpartum may represent a key window for surveillance and earlier diagnosis. Identifying predictors, treatment patterns, and risk factors for adverse outcomes will help develop screening strategies to diagnose pregnancy-related cancer early and improve clinical management of these cases. Citation Format: Nicole C. Loroña, Je
背景:美国最近的数据显示,在过去十年中,早发性癌症(在50岁之前诊断出来)的发病率在上升,其中30-39岁年龄组的发病率增幅最大,40-49岁年龄组的病例数最多。与此同时,产妇怀孕时的年龄也在增加,现在有38%的头胎发生在30岁及以上的妇女中。早发性癌症发病率的增加,加上母亲年龄的增加,可能导致更多的癌症在怀孕期间或产后被诊断出来。本研究描述了怀孕期间和产后癌症发病率的趋势,并确定了怀孕相关癌症的预测因素。方法:我们在大洛杉矶地区的一个大型卫生系统中确定了2015年至2023年期间至少有一次健康遭遇的成人癌症病例。我们确定了患有产科国际疾病分类(ICD-10)代码和/或肿瘤记录的患者,这些患者在癌症诊断前两年和诊断后六个月内怀孕。妊娠相关癌症定义为在怀孕期间或产后两年内(分娩、流产或宫外孕后)诊断出的癌症。描述性统计描述了人口统计学和癌症相关因素。结果:在研究期间的40432例癌症患者中,我们在216例患者中发现了217例与妊娠相关的癌症[1例患者在妊娠后诊断为甲状腺癌,随后在妊娠期间诊断为乳腺癌]。癌症诊断的中位年龄为37岁(范围:24-50岁)。13%的患者为亚洲人,6%为黑人或非裔美国人,15%为西班牙裔,56%为非西班牙裔白人。大多数(n=193, 92%)妊娠相关肿瘤为实体瘤(8%为血液学肿瘤),其中最常见的部位为乳腺(n= 85, 44%)、甲状腺(n= 35, 18%)、宫颈(n= 13, 7%)、中枢神经系统(n= 11, 6%)、卵巢(n= 8, 4%)和结肠(n= 6, 3%)。大多数实体瘤在早期被诊断出来(50%的I期,21%的II期,11%的III期,9%的IV期),15例原位癌被诊断出来(6例乳腺癌,6例妇科恶性肿瘤,3例黑色素瘤)。60例癌症是在怀孕期间诊断出来的(33%乳腺癌和13%甲状腺癌),91例是在产后一年内诊断出来的(32%乳腺癌和20%甲状腺癌),66例是在产后一到两年内诊断出来的(55%乳腺癌和14%甲状腺癌)。对妊娠相关癌症的总发病率和预测因素的分析正在进行中。结论:妊娠相关癌症对母胎护理和肿瘤学提出了挑战。产后两年的间隔可能是监测和早期诊断的关键窗口。确定不良后果的预测因素、治疗模式和危险因素将有助于制定筛查策略,以早期诊断妊娠相关癌症,并改善这些病例的临床管理。引用格式:Nicole C. Loroña, Jenny Harris, Jane C. Figueiredo。早发性癌症:以妊娠相关病例为重点[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): no B037。
{"title":"Abstract B037: Early-Onset Cancer: A Focus on Pregnancy-Associated Cases","authors":"Nicole C. Loroña, Jenny Harris, Jane C. Figueiredo","doi":"10.1158/1557-3265.earlyonsetca25-b037","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b037","url":null,"abstract":"Background: Recent data in the U.S. show a rising rate of early-onset cancers (diagnosed before age 50) over the past decade, with the largest increase in rates seen in the 30-39 age group and the highest number of cases in the 40-49 age group. Simultaneously, the maternal age at the time of pregnancy has increased, with 38% of first births now occurring in women aged 30 and older. The increasing incidence of early-onset cancer, coupled with increasing maternal age, could result in more cancers diagnosed during pregnancy or postpartum. The present study describes trends in the incidence of cancer during pregnancy and postpartum and identifies predictors of pregnancy-associated cancers. Methods: We identified cancer cases diagnosed in adults from 2015 to 2023 with at least one health encounter in the time frame in a large health system in the greater Los Angeles area. We identified patients with obstetric International Classification of Diseases (ICD-10) codes and/or oncology notes mentioning pregnancy in the two years before and six months following the patient’s date of cancer diagnosis. Pregnancy-associated cancer was defined as a diagnosis during pregnancy or within two years postpartum (following any birth, miscarriage, or ectopic pregnancy). Descriptive statistics characterized demographic and cancer-related factors. Results: Among 40,432 patients with cancer during the study period, we identified 217 pregnancy-associated cancers in 216 patients [one individual had thyroid cancer diagnosed following a pregnancy, and breast cancer in a subsequent pregnancy]. Median age at cancer diagnosis was 37 (range: 24-50). 13% of patients were Asian, 6% were Black or African American,15% were Hispanic, and 56% were non-Hispanic White. The majority (n=193, 92%) of pregnancy-associated cancers were solid tumors (vs. 8% hematological), of which the most common sites were breast (N=85, 44%), thyroid (N=35, 18%), cervix (N=13, 7%), central nervous system (N=11, 6%), ovarian (N=8, 4%) and colon (N=6, 3%). Most solid tumors were diagnosed at early stages (50% stage I, 21% stage II vs. 11% stage III, 9% stage IV), with 15 in situ cancers diagnosed (6 breast cancer, 6 gynecologic malignancies, and 3 melanoma). 60 cancers were diagnosed during pregnancy (33% breast and 13% thyroid cancer), 91 during one year postpartum (32% breast and 20% thyroid cancer), and 66 between one and two years postpartum (55% breast and 14% thyroid cancer). Analyses of the total incidence of and predictors of pregnancy-associated cancer are ongoing. Conclusions: Pregnancy-related cancers present challenges for maternal-fetal care and oncology. The two-year interval postpartum may represent a key window for surveillance and earlier diagnosis. Identifying predictors, treatment patterns, and risk factors for adverse outcomes will help develop screening strategies to diagnose pregnancy-related cancer early and improve clinical management of these cases. Citation Format: Nicole C. Loroña, Je","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"1 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-b029
Atharva Railkar, Amir Hernandez, Jennifer Molokwu
Colorectal cancer (CRC) is the second leading cause of cancer mortality for both men and women in the United States. While the general incidence of CRC among older adults has decreased since the 1990s, CRC incidence in younger adults has increased during the same time span. Surveillance data specifically reveal a hotspot of CRC incidence along the U.S.-Mexico border near El Paso, Texas, with an upward trend even as statewide rates have plateaued. Despite these observed disparities, there is limited data on early-onset CRC patterns in border communities. This study is a secondary analysis of data derived from a case-control study conducted between 2011 and 2023 to describe the health status of an outpatient population in El Paso, Texas. The sample population (n = 818) was identified from patients in the parent study who were cases and had a CRC diagnosis. This study investigated differences in the health status, comorbidities, and biomarkers in individuals diagnosed with CRC before age 50 (early-onset, EO-CRC) and those diagnosed at or after age 50 (late-onset, LO-CRC) in a predominantly Hispanic population along the U.S.-Mexico border. Results indicated that EO-CRC patients had higher rates of being uninsured (22.6%), having private insurance (54.1%), and reporting higher household incomes (p = 0.047). They were also more likely to have metastatic cancer (OR: 0.650; 95% CI: 0.457, 0.925; p = 0.016) and to have a family history of cancer (OR: 0.276; 95% CI: 0.117, 0.652; p = 0.002). In contrast, LO-CRC patients exhibited greater comorbidity burden, including significantly higher prevalence of heart failure, hypertension, renal failure, and type II diabetes. LO-CRC patients were also more likely to have been prescribed medications such as aspirin (OR: 5.472; 95% CI: 2.819, 10.618; p < 0.001) and statins (OR: 3.470; 95% CI: 2.092, 5.758; p < 0.001). Biomarker analysis revealed that EO-CRC patients had higher aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein, and alkaline phosphatase levels compared to LO-CRC patients, while LO-CRC patients had higher blood urea nitrogen, creatinine, glucose, and potassium levels. These findings underscore meaningful clinical and demographic distinctions between EO-CRC and LO-CRC that may reflect unique etiologic pathways, access challenges, and behavioral factors. Younger CRC patients tended to have lower Elixhauser risk scores and fewer comorbidities, which aligns with previous studies suggesting that EO-CRC patients may otherwise be relatively healthy at diagnosis. The higher metastatic burden among younger patients adds urgency to improving symptom recognition in younger adults. It suggests that existing screening and diagnostic models may miss warning signs in younger populations. As EO-CRC incidence increases, particularly among Hispanic populations, targeted, age-sensitive approaches to prevention, diagnosis, and care are essential for improving outcomes and reducing
结直肠癌(CRC)是美国男性和女性癌症死亡的第二大原因。虽然自20世纪90年代以来,老年人中CRC的一般发病率有所下降,但在同一时间段内,年轻人中CRC的发病率有所增加。监测数据特别揭示了靠近德克萨斯州埃尔帕索的美国-墨西哥边境地区的CRC发病率热点,即使在全州范围内的发病率趋于稳定时,该地区仍有上升趋势。尽管存在这些观察到的差异,但关于边境社区早发性CRC模式的数据有限。本研究是对2011年至2023年间进行的一项病例对照研究数据的二次分析,该研究描述了德克萨斯州埃尔帕索门诊人口的健康状况。样本人群(n = 818)是从父母研究中确诊为结直肠癌的病例患者中确定的。本研究调查了50岁前诊断为结直肠癌(早发性,EO-CRC)和50岁或50岁后诊断为结直肠癌(晚发性,LO-CRC)的人群的健康状况、合并症和生物标志物的差异。研究对象主要是美墨边境的西班牙裔人群。结果显示,EO-CRC患者无保险(22.6%)、有私人保险(54.1%)、家庭收入较高(p = 0.047)。他们也更有可能患有转移性癌症(OR: 0.650; 95% CI: 0.457, 0.925; p = 0.016)和有癌症家族史(OR: 0.276; 95% CI: 0.117, 0.652; p = 0.002)。相比之下,低结直肠癌患者表现出更大的合并症负担,包括心力衰竭、高血压、肾衰竭和II型糖尿病的患病率明显更高。低结直肠癌患者也更有可能服用阿司匹林(OR: 5.472; 95% CI: 2.819, 10.618; p < 0.001)和他汀类药物(OR: 3.470; 95% CI: 2.092, 5.758; p < 0.001)。生物标志物分析显示,EO-CRC患者的天冬氨酸转氨酶、丙氨酸转氨酶、高密度脂蛋白和碱性磷酸酶水平高于LO-CRC患者,而LO-CRC患者的血尿素氮、肌酐、葡萄糖和钾水平较高。这些发现强调了EO-CRC和LO-CRC之间有意义的临床和人口学差异,这些差异可能反映了独特的病因途径、获取挑战和行为因素。年轻的CRC患者往往具有较低的Elixhauser风险评分和较少的合并症,这与先前的研究一致,表明EO-CRC患者在诊断时可能相对健康。年轻患者中较高的转移性负担增加了改善年轻人症状识别的紧迫性。这表明,现有的筛查和诊断模式可能会错过年轻人群的警告信号。随着EO-CRC发病率的增加,特别是在西班牙裔人群中,有针对性的、对年龄敏感的预防、诊断和护理方法对于改善结果和缩小差距至关重要。引文格式:Atharva Railkar, Amir Hernandez, Jennifer Molokwu。美墨边境人群早发性和晚发性结直肠癌的临床和社会人口学关联[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): B029。
{"title":"Abstract B029: Clinical and Sociodemographic Associations Between Early-Onset and Late-Onset Colorectal Cancer in a U.S.–Mexico Border Population","authors":"Atharva Railkar, Amir Hernandez, Jennifer Molokwu","doi":"10.1158/1557-3265.earlyonsetca25-b029","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b029","url":null,"abstract":"Colorectal cancer (CRC) is the second leading cause of cancer mortality for both men and women in the United States. While the general incidence of CRC among older adults has decreased since the 1990s, CRC incidence in younger adults has increased during the same time span. Surveillance data specifically reveal a hotspot of CRC incidence along the U.S.-Mexico border near El Paso, Texas, with an upward trend even as statewide rates have plateaued. Despite these observed disparities, there is limited data on early-onset CRC patterns in border communities. This study is a secondary analysis of data derived from a case-control study conducted between 2011 and 2023 to describe the health status of an outpatient population in El Paso, Texas. The sample population (n = 818) was identified from patients in the parent study who were cases and had a CRC diagnosis. This study investigated differences in the health status, comorbidities, and biomarkers in individuals diagnosed with CRC before age 50 (early-onset, EO-CRC) and those diagnosed at or after age 50 (late-onset, LO-CRC) in a predominantly Hispanic population along the U.S.-Mexico border. Results indicated that EO-CRC patients had higher rates of being uninsured (22.6%), having private insurance (54.1%), and reporting higher household incomes (p = 0.047). They were also more likely to have metastatic cancer (OR: 0.650; 95% CI: 0.457, 0.925; p = 0.016) and to have a family history of cancer (OR: 0.276; 95% CI: 0.117, 0.652; p = 0.002). In contrast, LO-CRC patients exhibited greater comorbidity burden, including significantly higher prevalence of heart failure, hypertension, renal failure, and type II diabetes. LO-CRC patients were also more likely to have been prescribed medications such as aspirin (OR: 5.472; 95% CI: 2.819, 10.618; p &lt; 0.001) and statins (OR: 3.470; 95% CI: 2.092, 5.758; p &lt; 0.001). Biomarker analysis revealed that EO-CRC patients had higher aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein, and alkaline phosphatase levels compared to LO-CRC patients, while LO-CRC patients had higher blood urea nitrogen, creatinine, glucose, and potassium levels. These findings underscore meaningful clinical and demographic distinctions between EO-CRC and LO-CRC that may reflect unique etiologic pathways, access challenges, and behavioral factors. Younger CRC patients tended to have lower Elixhauser risk scores and fewer comorbidities, which aligns with previous studies suggesting that EO-CRC patients may otherwise be relatively healthy at diagnosis. The higher metastatic burden among younger patients adds urgency to improving symptom recognition in younger adults. It suggests that existing screening and diagnostic models may miss warning signs in younger populations. As EO-CRC incidence increases, particularly among Hispanic populations, targeted, age-sensitive approaches to prevention, diagnosis, and care are essential for improving outcomes and reducing ","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"13 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-a035
Chase V. West, Humberto R. Nieves-Jiménez, Matthew Washko, Ahmed Alderazi, Mohannad Safadi, Saadia A. Faiz
Castleman disease (CD) is a rare condition characterized by lymph node hyperplasia and immune dysregulation, often presenting as a spectrum of disorders rather than a single entity. Although not a malignancy in the traditional sense, CD exhibits overlapping neoplastic features, creating diagnostic and therapeutic challenges. It is classified as either a localized (unicentric) or diffuse (multicentric) process, with unicentric CD (UCD) presenting at a younger age. We present a UCD case complicated by paraneoplastic pemphigus (PNP) and bronchiolitis obliterans (BO), demonstrating the diagnostic complexity and importance of prompt recognition and treatment. An asymptomatic 38-year-old woman was referred for evaluation of a 7.2-cm middle mediastinal mass adjacent to the trachea initially noticed abroad. The patient underwent CT-guided core needle biopsy which demonstrated reactive lymphoid tissue and an expanded paracortex, and was initially monitored without intervention. Within two months, she developed an intermittent dry cough with shortness of breath (SOB), for which empiric antibiotics and low-dose steroids were prescribed for presumed respiratory infection, although to no resolution. The patient was evaluated by pulmonology, in which pulmonary function testing revealed a fixed obstructive pattern. Concurrently, painful oral ulcers were evaluated by oral surgery, and buccal biopsy specimen showed microscopic and direct immunofluorescence findings concerning for PNP. Subsequent dermatologic evaluation included a PNP antibody panel which confirmed desmoglein-3 and envoplakin antibodies. Given worsening SOB and dyspnea at rest, the patient presented to the emergency department, and CT chest demonstrated tapering of multiple distal bronchi with hyperlucency of the lungs, consistent with BO. She was admitted and started on high-dose steroids (methylprednisolone 1g/day ×3 days), in addition to intravenous immunoglobulin (IVIG) (2 g/kg total), endorsed by rheumatology. As the mass was considered the primary driver of the paraneoplastic process, cardiothoracic surgery successfully resected the now-enlarged 9.1-cm mediastinal lesion; pathology confirmed hyaline-vascular CD. The patient experienced an uncomplicated postoperative recovery. After five days of observation, the patient denied SOB, weakness or fatigue, and was saturating comfortably on room air. A total of four cycles of IVIG were completed, and a long-term steroid taper was issued, along with appropriate Pneumocystis jirovecii pneumonia and gastrointestinal prophylaxis. This case underscores the importance of early recognition and treatment of CD. Despite its rarity, the tendency of the disease to affect younger patients emphasizes the need for a high index of suspicion when evaluating nonspecific systemic manifestations. The presence of a single mass can mimic multiple other etiologies, complicating the clinical picture and potentially delaying diagnosis. A comprehensive assessment coupled
Castleman病(CD)是一种以淋巴结增生和免疫失调为特征的罕见疾病,通常表现为一系列疾病,而不是单一的疾病。虽然不是传统意义上的恶性肿瘤,但乳糜泻表现出重叠的肿瘤特征,给诊断和治疗带来了挑战。它分为局部(单中心)或弥漫性(多中心)病变,单中心性CD (UCD)出现于较年轻的年龄。我们报告了一例合并副肿瘤天疱疮(PNP)和闭塞性细支气管炎(BO)的UCD病例,证明了诊断的复杂性和及时识别和治疗的重要性。一名无症状的38岁妇女被转介评估一个7.2厘米的中纵隔肿块邻近的气管最初发现在国外。患者接受了ct引导下的核心针活检,显示淋巴组织反应性和皮层旁肿大,并在没有干预的情况下进行了初步监测。在两个月内,她出现了间歇性干咳和呼吸急促(SOB),医生给她开了经验性抗生素和低剂量类固醇,以治疗疑似呼吸道感染,但没有得到解决。通过肺部检查对患者进行评估,肺功能检查显示固定的阻塞性模式。同时,通过口腔手术评估疼痛性口腔溃疡,口腔活检标本显示与PNP有关的显微镜和直接免疫荧光结果。随后的皮肤病学评估包括PNP抗体小组,确认了desmoglin -3和envoplakin抗体。由于静息时呜咽加重和呼吸困难,患者到急诊科就诊,胸部CT示多根远端支气管变细,肺透光高,符合BO。她入院并开始使用高剂量类固醇(甲基强的松龙1g/天×3天),以及经风湿病学认可的静脉注射免疫球蛋白(IVIG)(共2g /kg)。由于肿块被认为是副肿瘤进程的主要驱动因素,心胸外科手术成功切除了现已扩大的9.1 cm纵隔病变;病理证实透明血管性CD。患者术后恢复简单。经过5天的观察,病人否认有哽咽、虚弱或疲劳,并舒适地呼吸室内空气。总共完成了四个周期的IVIG治疗,并给予长期类固醇减量治疗,同时给予适当的肺囊虫肺炎和胃肠道预防治疗。本病例强调了早期识别和治疗乳糜泻的重要性。尽管乳糜泻罕见,但该病易影响年轻患者,因此在评估非特异性全身表现时需要高度怀疑。单个肿块的出现可以模拟多种其他病因,使临床情况复杂化,并可能延迟诊断。综合评估加上多学科合作可能最终提高取得有利结果的可能性。引文格式:Chase V. West, Humberto R. nieves - jimsamunez, Matthew Washko, Ahmed Alderazi, Mohannad Safadi, Saadia A. Faiz。复杂的临床演变:纵隔单中心Castleman病先于副肿瘤天疱疮和闭塞性细支气管炎[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): no A035。
{"title":"Abstract A035: A complex clinical evolution: Mediastinal unicentric Castleman disease preceding paraneoplastic pemphigus and bronchiolitis obliterans","authors":"Chase V. West, Humberto R. Nieves-Jiménez, Matthew Washko, Ahmed Alderazi, Mohannad Safadi, Saadia A. Faiz","doi":"10.1158/1557-3265.earlyonsetca25-a035","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-a035","url":null,"abstract":"Castleman disease (CD) is a rare condition characterized by lymph node hyperplasia and immune dysregulation, often presenting as a spectrum of disorders rather than a single entity. Although not a malignancy in the traditional sense, CD exhibits overlapping neoplastic features, creating diagnostic and therapeutic challenges. It is classified as either a localized (unicentric) or diffuse (multicentric) process, with unicentric CD (UCD) presenting at a younger age. We present a UCD case complicated by paraneoplastic pemphigus (PNP) and bronchiolitis obliterans (BO), demonstrating the diagnostic complexity and importance of prompt recognition and treatment. An asymptomatic 38-year-old woman was referred for evaluation of a 7.2-cm middle mediastinal mass adjacent to the trachea initially noticed abroad. The patient underwent CT-guided core needle biopsy which demonstrated reactive lymphoid tissue and an expanded paracortex, and was initially monitored without intervention. Within two months, she developed an intermittent dry cough with shortness of breath (SOB), for which empiric antibiotics and low-dose steroids were prescribed for presumed respiratory infection, although to no resolution. The patient was evaluated by pulmonology, in which pulmonary function testing revealed a fixed obstructive pattern. Concurrently, painful oral ulcers were evaluated by oral surgery, and buccal biopsy specimen showed microscopic and direct immunofluorescence findings concerning for PNP. Subsequent dermatologic evaluation included a PNP antibody panel which confirmed desmoglein-3 and envoplakin antibodies. Given worsening SOB and dyspnea at rest, the patient presented to the emergency department, and CT chest demonstrated tapering of multiple distal bronchi with hyperlucency of the lungs, consistent with BO. She was admitted and started on high-dose steroids (methylprednisolone 1g/day ×3 days), in addition to intravenous immunoglobulin (IVIG) (2 g/kg total), endorsed by rheumatology. As the mass was considered the primary driver of the paraneoplastic process, cardiothoracic surgery successfully resected the now-enlarged 9.1-cm mediastinal lesion; pathology confirmed hyaline-vascular CD. The patient experienced an uncomplicated postoperative recovery. After five days of observation, the patient denied SOB, weakness or fatigue, and was saturating comfortably on room air. A total of four cycles of IVIG were completed, and a long-term steroid taper was issued, along with appropriate Pneumocystis jirovecii pneumonia and gastrointestinal prophylaxis. This case underscores the importance of early recognition and treatment of CD. Despite its rarity, the tendency of the disease to affect younger patients emphasizes the need for a high index of suspicion when evaluating nonspecific systemic manifestations. The presence of a single mass can mimic multiple other etiologies, complicating the clinical picture and potentially delaying diagnosis. A comprehensive assessment coupled ","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"7 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-b015
Belinda L. Gorsuch, Jim Z. Mai, Martha S. Linet, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Cari M. Kitahara, Elizabeth K. Cahoon
Importance Given the large and growing burden of keratinocyte carcinomas (KCs) in the United States, there is a pressing need to identify individuals at high risk. Objective To quantify the association between KC risk and history of blistering sunburns in childhood and adulthood and to investigate whether individual sun sensitivity and other measures of ultraviolet radiation modify these associations. Design We examined blistering sunburns and KC risk in the nationwide U.S. Radiologic Technologists cohort study. Baseline data (1983-2005) on lifetime sunburn history and sun sensitivity traits were collected via self-administered questionnaires. Participants were followed until the diagnosis of a first primary cancer or completion of a follow-up questionnaire (2012-2014). Setting United StatesParticipants Radiologic technologists without a prior cancer who reported White race or Hispanic ethnicity and completed both the baseline and follow-up questionnaires. Exposures History of blistering sunburns before (childhood) and after (adulthood) age 15 years. Main Outcomes and Measures Risk increase for basal and squamous cell carcinoma (BCC/SCC) per blistering sunburn. Results Among 40,204 radiologic technologists (2% Hispanic; mean age at baseline:56 years), those reporting at least one blistering sunburn had a 37% higher risk of BCC and a 41% higher risk of SCC. The risk of BCC increased by 6% (95% confidence interval [95% CI], 5-7) and 5% (95% CI, 4-6) for each childhood and adulthood blistering sunburns, respectively. Similar findings were observed for SCC, with risk increasing by 8% (95% CI, 6-11) and 7% (95% CI, 5-9) for childhood and adulthood blistering sunburns, respectively. These associations were not significantly modified by most individual sun sensitivity traits and other measures of ultraviolet radiation. Conclusions and Relevance Individuals with ≥5 blistering sunburns occurring across varying ages of exposure appear to be at particularly high risk for KCs and may benefit from heightened skin cancer surveillance. Citation Format: Belinda L. Gorsuch, Jim Z. Mai, Martha S. Linet, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Cari M. Kitahara, Elizabeth K. Cahoon. Impact of sun sensitivity and ultraviolet radiation on the association between blistering sunburns and keratinocyte carcinoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B015.
鉴于美国角化细胞癌(KCs)的巨大且不断增长的负担,迫切需要确定高危人群。目的量化儿童和成年期起泡性晒伤史与KC风险之间的关系,并探讨个体太阳敏感性和其他紫外线辐射措施是否可以改变这些关系。我们在美国全国放射技术人员队列研究中检查了晒伤起泡和KC风险。基线数据(1983-2005年)的一生晒伤史和太阳敏感性特征通过自我管理问卷收集。研究人员对参与者进行随访,直到诊断出第一原发性癌症或完成随访问卷(2012-2014)。背景:美国参与者:没有癌症病史的放射技术人员,报告为白人或西班牙裔,并完成基线和随访问卷。15岁之前(儿童)和15岁之后(成年)的晒伤史。主要结果和测量方法:每次晒伤会增加基底细胞癌和鳞状细胞癌(BCC/SCC)的风险。结果在40204名放射技师中(2%为西班牙裔,基线时平均年龄为56岁),报告至少有一次晒伤的人患BCC的风险高出37%,患SCC的风险高出41%。儿童期和成年期每次晒伤,BCC的风险分别增加6%(95%置信区间[95% CI], 5-7)和5% (95% CI, 4-6)。在SCC中也观察到类似的结果,儿童期和成年期晒伤的风险分别增加8% (95% CI, 6-11)和7% (95% CI, 5-9)。这些关联并没有被大多数个体的太阳敏感性特征和其他紫外线辐射测量显著改变。在不同年龄发生≥5次水泡性晒伤的个体似乎具有特别高的KCs风险,并且可能从加强皮肤癌监测中受益。引文格式:Belinda L. Gorsuch, Jim Z. Mai, Martha S. Linet, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Cari M. Kitahara, Elizabeth K. Cahoon。太阳敏感性和紫外线辐射对水泡性晒伤与角化细胞癌关系的影响[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): B015。
{"title":"Abstract B015: Impact of sun sensitivity and ultraviolet radiation on the association between blistering sunburns and keratinocyte carcinoma","authors":"Belinda L. Gorsuch, Jim Z. Mai, Martha S. Linet, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Cari M. Kitahara, Elizabeth K. Cahoon","doi":"10.1158/1557-3265.earlyonsetca25-b015","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b015","url":null,"abstract":"Importance Given the large and growing burden of keratinocyte carcinomas (KCs) in the United States, there is a pressing need to identify individuals at high risk. Objective To quantify the association between KC risk and history of blistering sunburns in childhood and adulthood and to investigate whether individual sun sensitivity and other measures of ultraviolet radiation modify these associations. Design We examined blistering sunburns and KC risk in the nationwide U.S. Radiologic Technologists cohort study. Baseline data (1983-2005) on lifetime sunburn history and sun sensitivity traits were collected via self-administered questionnaires. Participants were followed until the diagnosis of a first primary cancer or completion of a follow-up questionnaire (2012-2014). Setting United StatesParticipants Radiologic technologists without a prior cancer who reported White race or Hispanic ethnicity and completed both the baseline and follow-up questionnaires. Exposures History of blistering sunburns before (childhood) and after (adulthood) age 15 years. Main Outcomes and Measures Risk increase for basal and squamous cell carcinoma (BCC/SCC) per blistering sunburn. Results Among 40,204 radiologic technologists (2% Hispanic; mean age at baseline:56 years), those reporting at least one blistering sunburn had a 37% higher risk of BCC and a 41% higher risk of SCC. The risk of BCC increased by 6% (95% confidence interval [95% CI], 5-7) and 5% (95% CI, 4-6) for each childhood and adulthood blistering sunburns, respectively. Similar findings were observed for SCC, with risk increasing by 8% (95% CI, 6-11) and 7% (95% CI, 5-9) for childhood and adulthood blistering sunburns, respectively. These associations were not significantly modified by most individual sun sensitivity traits and other measures of ultraviolet radiation. Conclusions and Relevance Individuals with ≥5 blistering sunburns occurring across varying ages of exposure appear to be at particularly high risk for KCs and may benefit from heightened skin cancer surveillance. Citation Format: Belinda L. Gorsuch, Jim Z. Mai, Martha S. Linet, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Cari M. Kitahara, Elizabeth K. Cahoon. Impact of sun sensitivity and ultraviolet radiation on the association between blistering sunburns and keratinocyte carcinoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B015.","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"29 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-c021
Peter Georgeson, Jihoon E. Joo, Alysha Prisc, Lochlan Fennell, Liam Skinner, Bernard J. Pope, Khalid Mahmood, Romy Walker, Mark Clendenning, Julia Como, Natalie Diepenhorst, Julie McDonald, Finlay A. Macrae, Christophe Rosty, Ingrid M. Winship, Amanda Phipps, Mark A. Jenkins, Ulrike Peters, Daniel D. Buchanan
Introduction: Colorectal cancers (CRCs)with related colibactin-induced DNA damage from pks+E.coli bacteria are identified by the presence of the SBS88 tumor mutational signature and mutations in unique 5bp genomic contexts (extended contexts). CRCs with high SBS88 and high extended contexts (colibactin-positive) remain poorly characterized in terms of identifying distinct clinicopathological, genomic, and transcriptomic features. Methods: We applied a mutational signature-based classifier derived from organoid sequencing data to identify colibactin-positive CRCs in 1,716 non-hereditary, microsatellite stable (MSS) whole-genome sequenced primary tumors from Genomics England (GEL). Clinicopathological, genomic and survival associations were tested in an independent cohort of 4,254 primary MSS CRCs from the GECCO-CCFR consortium. Spatial transcriptomic profiling of the tumor microenvironment of colibactin-positive EOCRCs was performed using Nanostring CosMx technology. Results: Colibactin-positive CRCs were identified in 10.2% (175/1,716) of the GEL CRCs and were associated with an early age at diagnosis (<40 years: 4.0% of positives v 2.0% of negatives; p=0.1), enrichment in patients born on or after 1980 (6.9% v 1.4%; p=0.02), and location in distal colon and rectum compared with proximal colon (45%/47% v 41%/28% distal/rectum; p=5x10-11) when compared with the colibactin-negative CRCs (n=1,400, 81%). Genomic analysis revealed recurrent mutations in established CRC driver genes, the strongest of which were APC:c.835-8A>G (p=1x10-12), SMAD4:c.788-8A>G (p=0.0001) and BRAF:c.1781A>G (p=0.001), with mutations exhibiting site-specificity. Colibactin-positive CRCs exhibited distinctive large-scale genomic alterations, including recurrent loss of heterozygosity spanning TGIF1, SMAD2, DCC, and SMAD4 gene region. Mutation timing analysis revealed that SBS88-associated mutations, extended context mutations and APC:c.835-8A>G are early, clonal events (p=3x10-35, 7x10-81, 3x10-9 respectively). In the GECCO-CCFR CRCs, 5.1% of 4,254 MSS CRCs were identified as colibactin-positive (216 of 4,254) with similar significant genomic hallmarks: earlier age at diagnosis (<50 years p=0.03), distal and rectum site (p=4x10-9), and recurrent mutations in APC, SMAD4 and BRAF (p=4x10-128, 2x10-9, 2x10-8). Spatial transcriptomic profiling of six EOCRCs (three colibactin-positive) obtained 1.5 million cells across 19 cell types. Our preliminary analyses identified distinct stromal and immunological profiles associated with colibactin-positive EOCRCs. Conclusions: A combined SBS88 and extended context mutational signature-based classifier for colibactin-induced DNA damage, identified a distinct subtype of CRC characterized by earlier age at diagnosis, distal and rectal site predominance, specific somatic mutations, and unique genomic instability patterns. These findings provide new insights into colibactin-mediated carcinogenesis and cr
结直肠癌(crc)与相关的大肠杆菌素诱导的pks+E DNA损伤。大肠杆菌通过存在SBS88肿瘤突变特征和独特的5bp基因组背景(扩展背景)中的突变来鉴定。具有高SBS88和高扩展背景(大肠杆菌素阳性)的crc在识别不同的临床病理、基因组和转录组学特征方面仍然缺乏特征。方法:我们使用基于突变特征的分类器(源自类器官测序数据)来鉴定来自英国基因组公司(GEL)的1716例非遗传性、微卫星稳定(MSS)全基因组测序的原发性肿瘤中的大肠杆菌素阳性crc。在来自GECCO-CCFR联盟的4254例原发性MSS crc的独立队列中检测了临床病理学、基因组学和生存相关性。利用Nanostring CosMx技术对大肠杆菌素阳性eoccs的肿瘤微环境进行了空间转录组学分析。结果:10.2%(175/1,716)的GEL crc中鉴定出大肠杆菌素阳性crc,并与早期诊断年龄(40岁:4.0%阳性vs 2.0%阴性,p=0.1), 1980年或以后出生的患者中有丰富(6.9% v 1.4%, p=0.02),与大肠杆菌素阴性crc相比,位于结肠远端和直肠(45%/47% v 41%/28%远端/直肠;p=5 × 10-11)相关(n=1,400, 81%)。基因组分析显示,在已建立的CRC驱动基因中存在反复突变,其中最强的是APC:c.835-8A>;G (p=1x10-12), SMAD4:c.788-8A>;G (p=0.0001)和BRAF:c.1781A>;G (p=0.001),突变表现出位点特异性。大肠杆菌素阳性的crc表现出明显的大规模基因组改变,包括跨越TGIF1、SMAD2、DCC和SMAD4基因区域的杂合性复发性缺失。突变时间分析显示sbs88相关突变、扩展上下文突变和APC:c.835-8A>;G为早期克隆事件(p分别为3x10-35、7x10-81、3x10-9)。在GECCO-CCFR crc中,4254例MSS crc中有5.1%被鉴定为大肠杆菌素阳性(4254例中有216例),具有相似的显著基因组特征:诊断年龄更早(50岁p=0.03),远端和直肠部位(p=4x10-9), APC、SMAD4和BRAF复发突变(p=4x10-128、2x10-9、2x10-8)。6个eoccs(3个大肠杆菌素阳性)的空间转录组学分析获得了19种细胞类型的150万个细胞。我们的初步分析确定了与大肠杆菌素阳性eoccs相关的不同基质和免疫学特征。结论:结合SBS88和基于扩展上下文突变特征的大肠杆菌素诱导DNA损伤分类器,确定了CRC的一个独特亚型,其特征是诊断年龄较早,远端和直肠部位优势,特定的体细胞突变和独特的基因组不稳定模式。这些发现为大肠杆菌素介导的癌变提供了新的见解,并为开发大肠杆菌素相关CRC的靶向治疗和预防策略创造了机会。引文格式:Peter Georgeson, Jihoon E. Joo, Alysha Prisc, Lochlan Fennell, Liam Skinner, Bernard J. Pope, Khalid Mahmood, Romy Walker, Mark Clendenning, Julia Como, Natalie Diepenhorst, Julie McDonald, Finlay A. Macrae, Christophe Rosty, Ingrid M. Winship, Amanda Phipps, Mark A. Jenkins, Ulrike Peters, Daniel D. Buchanan。大肠杆菌素诱导结直肠癌的临床病理学、基因组学和空间转录组学特征表征[摘要]。摘自:美国癌症研究协会癌症研究特别会议论文集:早发性癌症的增加——知识差距和研究机会;2025年12月10-13日;加拿大蒙特利尔,QC。费城(PA): AACR;临床癌症研究2025;31(23_supl): no C021。
{"title":"Abstract C021: Characterizing the clinicopathological, genomic and spatial transcriptomic features of colibactin-induced colorectal cancers","authors":"Peter Georgeson, Jihoon E. Joo, Alysha Prisc, Lochlan Fennell, Liam Skinner, Bernard J. Pope, Khalid Mahmood, Romy Walker, Mark Clendenning, Julia Como, Natalie Diepenhorst, Julie McDonald, Finlay A. Macrae, Christophe Rosty, Ingrid M. Winship, Amanda Phipps, Mark A. Jenkins, Ulrike Peters, Daniel D. Buchanan","doi":"10.1158/1557-3265.earlyonsetca25-c021","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-c021","url":null,"abstract":"Introduction: Colorectal cancers (CRCs)with related colibactin-induced DNA damage from pks+E.coli bacteria are identified by the presence of the SBS88 tumor mutational signature and mutations in unique 5bp genomic contexts (extended contexts). CRCs with high SBS88 and high extended contexts (colibactin-positive) remain poorly characterized in terms of identifying distinct clinicopathological, genomic, and transcriptomic features. Methods: We applied a mutational signature-based classifier derived from organoid sequencing data to identify colibactin-positive CRCs in 1,716 non-hereditary, microsatellite stable (MSS) whole-genome sequenced primary tumors from Genomics England (GEL). Clinicopathological, genomic and survival associations were tested in an independent cohort of 4,254 primary MSS CRCs from the GECCO-CCFR consortium. Spatial transcriptomic profiling of the tumor microenvironment of colibactin-positive EOCRCs was performed using Nanostring CosMx technology. Results: Colibactin-positive CRCs were identified in 10.2% (175/1,716) of the GEL CRCs and were associated with an early age at diagnosis (&lt;40 years: 4.0% of positives v 2.0% of negatives; p=0.1), enrichment in patients born on or after 1980 (6.9% v 1.4%; p=0.02), and location in distal colon and rectum compared with proximal colon (45%/47% v 41%/28% distal/rectum; p=5x10-11) when compared with the colibactin-negative CRCs (n=1,400, 81%). Genomic analysis revealed recurrent mutations in established CRC driver genes, the strongest of which were APC:c.835-8A&gt;G (p=1x10-12), SMAD4:c.788-8A&gt;G (p=0.0001) and BRAF:c.1781A&gt;G (p=0.001), with mutations exhibiting site-specificity. Colibactin-positive CRCs exhibited distinctive large-scale genomic alterations, including recurrent loss of heterozygosity spanning TGIF1, SMAD2, DCC, and SMAD4 gene region. Mutation timing analysis revealed that SBS88-associated mutations, extended context mutations and APC:c.835-8A&gt;G are early, clonal events (p=3x10-35, 7x10-81, 3x10-9 respectively). In the GECCO-CCFR CRCs, 5.1% of 4,254 MSS CRCs were identified as colibactin-positive (216 of 4,254) with similar significant genomic hallmarks: earlier age at diagnosis (&lt;50 years p=0.03), distal and rectum site (p=4x10-9), and recurrent mutations in APC, SMAD4 and BRAF (p=4x10-128, 2x10-9, 2x10-8). Spatial transcriptomic profiling of six EOCRCs (three colibactin-positive) obtained 1.5 million cells across 19 cell types. Our preliminary analyses identified distinct stromal and immunological profiles associated with colibactin-positive EOCRCs. Conclusions: A combined SBS88 and extended context mutational signature-based classifier for colibactin-induced DNA damage, identified a distinct subtype of CRC characterized by earlier age at diagnosis, distal and rectal site predominance, specific somatic mutations, and unique genomic instability patterns. These findings provide new insights into colibactin-mediated carcinogenesis and cr","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"5 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10DOI: 10.1158/1557-3265.earlyonsetca25-b006
Barbara ADJEI-MENSAH, PATIENCE PEPRA-AMEYAW
Objective: Colorectal cancer (CRC) ranks 8th in cancer-related mortality in Ghana. Globally, it is the third most common cancer and second in cancer-related deaths. Early-onset colorectal cancer (EOCRC), defined as CRC occurring before age 50, is rising. This study reviews the prevalence of EOCRC, the histological grade, and pathological stage at tumour resection. Methods: A retrospective analysis of histopathology records at the Pathology Department, Korle Bu Teaching Hospital, Accra was conducted. Colorectal cancer cases diagnosed between 2015 and 2024 were reviewed. Data on patients aged 18–49 were extracted and analysed using STATA 14. Results: Over the ten-year review period, 44 cases of early-onset colorectal cancer (EOCRC) were diagnosed following surgical resection, representing 22.6% of all colorectal cancer diagnoses during the same period. The male-to-female ratio was 1.3 to 1, indicating a slight male predominance. Most patients were between 40 and 49 years old, accounting for 47.7% of cases. The least diagnoses were recorded in the 20 to 29 age group, comprising only 11.4%. Histologically, 50% of the tumors were classified as well-differentiated adenocarcinomas. Moderately differentiated adenocarcinomas accounted for 45.5%, while 6.8% were poorly differentiated. According to the TNM classification, 18.2% of tumors were staged as T2, indicating invasion of the muscularis propria. A larger proportion, 47.7%, were T3 tumors- the tumor had invaded the subserosa or non-peritonealized pericolic or perirectal tissues. T4 tumors, which invade adjacent organs or perforate the visceral peritoneum, made up 34.1% of the cases. 54.5% of patients had no regional lymph node metastasis (N0). About 15.9% had metastases in one to three lymph nodes (N1), while 25% had involvement of four or more regional lymph nodes (N2). In 4.5% of the cases, lymph node status could not be assessed (NX). Conclusion: Over one in five colorectal cancer cases occurred in individuals under 50, and mostly presenting at advanced local tumour stages. These findings highlight the need for increased awareness and early screening for CRCs in Ghana. Citation Format: barbara adjei- mensah, patience pepra- ameyaw. Early-onset colorectal cancer: 10 year review of histopathological trends in a tertiary hospital in Accra, Ghana [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B006.
{"title":"Abstract B006: Early-onset colorectal cancer: 10 year review of histopathological trends in a tertiary hospital in Accra, Ghana","authors":"Barbara ADJEI-MENSAH, PATIENCE PEPRA-AMEYAW","doi":"10.1158/1557-3265.earlyonsetca25-b006","DOIUrl":"https://doi.org/10.1158/1557-3265.earlyonsetca25-b006","url":null,"abstract":"Objective: Colorectal cancer (CRC) ranks 8th in cancer-related mortality in Ghana. Globally, it is the third most common cancer and second in cancer-related deaths. Early-onset colorectal cancer (EOCRC), defined as CRC occurring before age 50, is rising. This study reviews the prevalence of EOCRC, the histological grade, and pathological stage at tumour resection. Methods: A retrospective analysis of histopathology records at the Pathology Department, Korle Bu Teaching Hospital, Accra was conducted. Colorectal cancer cases diagnosed between 2015 and 2024 were reviewed. Data on patients aged 18–49 were extracted and analysed using STATA 14. Results: Over the ten-year review period, 44 cases of early-onset colorectal cancer (EOCRC) were diagnosed following surgical resection, representing 22.6% of all colorectal cancer diagnoses during the same period. The male-to-female ratio was 1.3 to 1, indicating a slight male predominance. Most patients were between 40 and 49 years old, accounting for 47.7% of cases. The least diagnoses were recorded in the 20 to 29 age group, comprising only 11.4%. Histologically, 50% of the tumors were classified as well-differentiated adenocarcinomas. Moderately differentiated adenocarcinomas accounted for 45.5%, while 6.8% were poorly differentiated. According to the TNM classification, 18.2% of tumors were staged as T2, indicating invasion of the muscularis propria. A larger proportion, 47.7%, were T3 tumors- the tumor had invaded the subserosa or non-peritonealized pericolic or perirectal tissues. T4 tumors, which invade adjacent organs or perforate the visceral peritoneum, made up 34.1% of the cases. 54.5% of patients had no regional lymph node metastasis (N0). About 15.9% had metastases in one to three lymph nodes (N1), while 25% had involvement of four or more regional lymph nodes (N2). In 4.5% of the cases, lymph node status could not be assessed (NX). Conclusion: Over one in five colorectal cancer cases occurred in individuals under 50, and mostly presenting at advanced local tumour stages. These findings highlight the need for increased awareness and early screening for CRCs in Ghana. Citation Format: barbara adjei- mensah, patience pepra- ameyaw. Early-onset colorectal cancer: 10 year review of histopathological trends in a tertiary hospital in Accra, Ghana [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl): nr B006.","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"56 1","pages":""},"PeriodicalIF":11.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}